NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Research In Motion (BBRY) was upgraded at Morgan Stanley from underweight to overweight. $22 price target. Blackberry 10 should boost overall pricing and margins, Morgan Stanley said.
Walgreen (WAG) was upgraded at JP Morgan to to overweight from neutral. $55 price target. Transforming the global supply chain with new strategic relationship, JP Morgan said.
Adobe Systems (ADBE) downgraded at Stifel from buy to hold. Stock appears fully valued at current levels, Stifel Nicolaus said.Zynga (ZNGA)downgraded at BofA Merrill to neutral from buy. $3.90 price target. Risk reward less compelling, Bank of America Merrill Lynch said. Symantec (SYMC) downgraded at Oppenheimer from outperform to perform. Valuation call, as the stock is up 66% over the past 8 months, Oppenheimer said. Cimarex Energy (XEC) was downgraded at FBR from outperform to market pPerform. Valuation call, based on a $72 price target, FBR Capital Markets said. Emergent BioSolutions (EBS) was downgraded to hold at TheStreet Ratings. AmerisourceBergen (ABC) was upgraded at Citi to buy from neutral. The deal with Walgreens will be transformational, increasing international reach and adding purchasing power, said Citigroup. Price target is $62. AmerisourceBergen was downgraded at ISI from buy to neutral. Valuation call, based on a $54 price target, ISI Group said. Cardinal Health (CAH) downgraded at Citi to neutral from buy. The loss of the contract with Walgreens will limit earnings growth, said Citigroup. Price target is $43. Cardinal Health downgraded at ISI from strong buy to buy. $48.50 price target. Loss of WAG deal will cut into earnings, ISI Group said. Ocwen (OCN) was downgraded to hold at TheStreet Ratings. VMware (VMW) is rated new sector perform at FBN. $85 price target. Expect license growth to accelerate this year, FBN Securities said. Cimarex Energy (XEC) downgraded at FBR from outperform to market perform. Valuation call, based on a $72 price target, FBR Capital Markets said. Williams Partners (WPZ) initiated at UBS with a neutral rating. While the company is a dominant midstream provider, commodity sensitivity remains, said UBS. Price target is $50. STOCK COMMENTS/EPS CHANGES Apple (AAPL) estimates, target cut at Canaccord Genuity. Shares are now seen reaching $600. Estimates were also reduced, as the iPhone could lose market share this year, according to Canaccord Genuity.. Buy rating. Cobalt International (CIE) price target increased at UBS to $36. The appraisal of the Shenandoah well was impressive and the North Platt oil pay was above pre-drill estimates, said UBS.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV